We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

198 hedge funds and large institutions have $1.22B invested in Immunogen Inc in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 74 increasing their positions, 55 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 55

11% more capital invested

Capital invested by funds: $1.1B → $1.22B (+$119M)

1% more call options, than puts

Call options by funds: $8.07M | Put options by funds: $8.01M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 204 → 198 (-6)

13% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 32

Holders
198
Holders Change
-6
Holders Change %
-2.94%
% of All Funds
4.53%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
28
Increased
74
Reduced
55
Closed
32
Calls
$8.07M
Puts
$8.01M
Net Calls
+$54K
Net Calls Change
+$18.7M

Top Buyers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
+$41.4M
2
RG
Redmile Group
California
+$27.6M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.3M
4
BlackRock
BlackRock
New York
+$21.9M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$21.7M

Top Sellers

Rank Fund Capital Flow
1
PC
PointState Capital
New York
-$17.6M
2
Millennium Management
Millennium Management
New York
-$14.5M
3
Franklin Resources
Franklin Resources
California
-$9.86M
4
Invesco
Invesco
Georgia
-$7.69M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$7.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
VEA
76
Virtus ETF Advisers
New York
$753K -$371K -35,182 -31%
PPA
77
Parametric Portfolio Associates
Washington
$745K -$909K -86,204 -53%
Stifel Financial
78
Stifel Financial
Missouri
$721K -$34.6K -3,278 -4%
Lazard Asset Management
79
Lazard Asset Management
New York
$718K – – –
BTS
80
BB&T Securities
Virginia
$712K -$36.7K -3,482 -5%
ProShare Advisors
81
ProShare Advisors
Maryland
$708K -$11.8K -1,124 -2%
TD Asset Management
82
TD Asset Management
Ontario, Canada
$704K +$176K +16,733 +30%
AQR Capital Management
83
AQR Capital Management
Connecticut
$680K -$123K -11,690 -14%
Citigroup
84
Citigroup
New York
$670K -$2.52M -238,849 -78%
ECM
85
Endurant Capital Management
California
$664K +$720K +68,265 New
VF
86
Virtu Financial
New York
$617K -$19.7K -1,871 -3%
N
87
Nuveen
North Carolina
$603K – – –
MIM
88
MetLife Investment Management
New Jersey
$581K +$145K +13,727 +30%
DekaBank Deutsche Girozentrale
89
DekaBank Deutsche Girozentrale
Germany
$564K – – –
PI
90
Putnam Investments
Massachusetts
$522K +$565K +53,605 New
Federated Hermes
91
Federated Hermes
Pennsylvania
$520K +$346K +32,812 +159%
MSL
92
Mackay Shields LLC
New York
$445K +$482K +45,700 New
MLICM
93
Metropolitan Life Insurance Company (MetLife)
New York
$411K +$90.1K +8,543 +25%
GC
94
Grace Capital
Massachusetts
$384K +$416K +39,500 New
NFC
95
Northeast Financial Consultants
Connecticut
$333K – – –
ECM
96
Element Capital Management
New York
$313K +$157K +14,937 +87%
LPL Financial
97
LPL Financial
California
$312K -$63K -5,973 -16%
BBI
98
Baxter Bros Inc
Connecticut
$300K -$264K -25,000 -45%
Simplex Trading
99
Simplex Trading
Illinois
$282K +$307K +29,076 New
Teacher Retirement System of Texas
100
Teacher Retirement System of Texas
Texas
$274K +$3.84K +364 +1%
2 3
4
5 6

IMGN Hedge Fund Activity: Q2 2018 in Review

198 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2018, worth a combined $1.22B — up 11% from $1.1B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of IMGN and 28 opened new positions — a net loss of 4 holders — while 55 trimmed existing stakes and 74 added.

The largest buyer was Capital Research Global Investors, adding an estimated $41.4M. The largest seller was PointState Capital, exiting entirely with an estimated $17.6M sold.

  • 198 institutional investors held Immunogen Inc (IMGN) as of Q2 2018, down from 204 in Q1 2018.
  • Funds reported $1.22B of Immunogen Inc stock for Q2 2018, up 11% quarter-over-quarter.
  • 28 funds opened new Immunogen Inc positions in Q2 2018 and 32 closed out, a net change of -4 holders.
  • The largest Immunogen Inc buyer in Q2 2018 was Capital Research Global Investors, an estimated $41.4M added.
  • The largest Immunogen Inc seller in Q2 2018 was PointState Capital, an estimated $17.6M sold.

Based on aggregated 13F filings for Q2 2018.